Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to 1.92.

  • Champions Oncology's Asset Utilization Ratio fell 986.66% to 1.92 in Q4 2025 from the same period last year, while for Oct 2025 it was 1.92, marking a year-over-year decrease of 986.66%. This contributed to the annual value of 1.95 for FY2025, which is 1735.51% up from last year.
  • Latest data reveals that Champions Oncology reported Asset Utilization Ratio of 1.92 as of Q4 2025, which was down 986.66% from 1.81 recorded in Q3 2025.
  • Champions Oncology's 5-year Asset Utilization Ratio high stood at 2.14 for Q4 2024, and its period low was 1.42 during Q2 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 1.6 (2023), whereas its average is 1.7.
  • As far as peak fluctuations go, Champions Oncology's Asset Utilization Ratio tumbled by 2824.1% in 2021, and later surged by 2433.8% in 2024.
  • Over the past 5 years, Champions Oncology's Asset Utilization Ratio (Quarter) stood at 1.55 in 2021, then decreased by 1.18% to 1.53 in 2022, then rose by 12.32% to 1.72 in 2023, then grew by 24.34% to 2.14 in 2024, then fell by 9.87% to 1.92 in 2025.
  • Its Asset Utilization Ratio stands at 1.92 for Q4 2025, versus 1.81 for Q3 2025 and 1.81 for Q2 2025.